Month: May 2024

VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN “HYTN” or “The Company”), a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds including cannabis, applauds the recent formal recommendation by the U.S. Justice Department, endorsed by the Drug Enforcement Agency (DEA), to reclassify cannabis from a Schedule I to a Schedule III controlled substance. This historic shift, pending review by the White House Office of Management and Budget (OMB), recognizes the medical utility of cannabis and its lower potential for abuse compared to substances in higher schedules. HYTN views this as a progressive move which harmonizes federal regulations with the evolving public and medical stance on cannabis. HYTN notes that such a change...

SOUTH SAN FRANCISCO, Calif., May 01, 2024 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced participation in the following May investor events.RBC Capital Markets Global Healthcare Conference Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer, and Éric Lefebvre, M.D., Pliant’s Chief Medical Officer, will participate in a fireside chat on Tuesday, May 14, 2024, at 1:35 p.m. Eastern Time. Stifel West Coast Bus Tour Members of Pliant’s senior management team will meet with investors on Thursday, May 23, 2024, as part of an invitation-only event hosted by Stifel. Piper Sandler Virtual Lung Investor Day Keith Cummings, M.D., Pliant’s Chief...

Pre-Recorded Earnings Call Webcast Will Be Available on Investor Relations Website LAS VEGAS, May 01, 2024 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods”, or the “Company”), a leading food distributor to Asian restaurants across the United States, today announced it will report financial results for the first quarter ended March 31, 2024, on Wednesday, May 8, 2024, before market open. Prepared remarks from members of the executive management team discussing these results with additional comments and details will be made available through the “Events” section of the Company’s Investor Relations website at https://investors.hffoodsgroup.com. The webcast will be archived and available for replay. About HF Foods Group Inc. HF Foods Group Inc. is a leading marketer and distributor of fresh produce, frozen and dry...

BOTHELL, Wash., May 01, 2024 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces completion of enrollment of 78 subjects who were infected with influenza A in a randomized, double-blind, placebo-controlled Phase 2a human challenge clinical study evaluating the safety, tolerability, antiviral and clinical measurements of its novel, broad-spectrum, oral PB2 inhibitor CC-42344. CC-42344 is a new class of antiviral treatment designed to effectively block an essential step in the viral replication and transcription of pandemic and seasonal influenza A, and was discovered using the Company’s proprietary structure-based drug discovery platform technology. “There is an urgent need for new influenza antivirals targeting highly pathogenic avian pandemic and seasonal influenza strains. It’s gratifying...

Acquisition Results in 100% Ownership of U.S. Business AUBURN HILLS, Mich., May 01, 2024 (GLOBE NEWSWIRE) — SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR,” “SPAR Group,” or the “Company”), a provider of merchandising, marketing, and distribution services, announces the acquisition of the remaining minority interest of Resource Plus, a U.S.-based joint venture. “SPAR established the joint venture with Resource Plus in 2017 to open new segments and expand the company’s capabilities. The JV agreement enabled SPAR to accelerate the growth of its remodel business over the last few years, including positioning the company as a service provider to the two largest home improvement retailers in the U.S.,” said Mike Matacunas, SPAR Group CEO. “This acquisition is another step in the strategic optimization and simplification of our business. We...

VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is excited to announce one of the leading US medical schools has agreed to a contract renewal utilizing Treatment’s Medical Education Suite (“MES”). Treatment is also in discussions with a number of other medical and nursing schools, both in the US and internationally. As reported previously, the market in the US alone comprises 300 medical schools; 900 nursing schools; 227,000 students and 145,000 residents/medical students.For schools, MES aims to (i) reduce associated time, resources and lower costs involved in creating national exams (i.e. MCQs; OSCE); (ii) minimize the administrative work in grading and (iii) create a consistent and real-time approach for case testing...

Genesee Repowering project hits major milestones EDMONTON, Alberta, May 01, 2024 (GLOBE NEWSWIRE) — Capital Power Corporation (TSX: CPX) today released financial results for the quarter ended March 31, 2024. Financial highlightsGenerated adjusted funds from operations (AFFO) of $142 million and net cash flows used in operating activities of $334 million Generated adjusted EBITDA of $279 million and a net income of $205 millionStrategic highlightsSuccessful commissioning began on Genesee repower unit 1 simple cycle and retired Genesee 1, a significant milestone towards our net-zero by 2045 goal. Provided updated cost on Genesee repower project as completion nears. Discontinuing pursuit of $2.4 billion Genesee carbon capture and storage (CCS) project. Completed acquisition of 100% interest in the La Paloma facility in California...

Two-year extension for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases CAMBRIDGE, Mass., May 01, 2024 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced a two-year extension to the collaboration with Bristol Myers Squibb (NYSE: BMY) under which the parties may research, develop, and commercialize autologous and allogeneic alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases. The extension also has options to extend the collaboration for up to an additional two years. Under the collaboration, Bristol Myers Squibb has opted into 13 different programs across 11 gene targets to date. Two programs are currently in IND-enabling studies, and four programs are in late-stage discovery. “Bristol...

Conference webcast to follow at 5:30 p.m. EDT DENVER, May 01, 2024 (GLOBE NEWSWIRE) — authID Inc. [Nasdaq: AUID], a leading provider of secure identity verification and authentication solutions, today announced the Company will report financial results for the first quarter ended March 31, 2024 on Wednesday, May 15, 2024 after market close. Following issuance of the earnings release, authID Chief Executive Officer Rhon Daguro and Chief Financial Officer Ed Sellitto will host a webcast at 5:30 p.m. EDT to discuss the financial results and provide a corporate update.To join the webcast, investors will need to register here: authID Q1 2024 Results Webcast RegistrationPlease note that the webcast will use the Zoom Events platform. Participants are advised to pre-register with a validated email address OR your existing Zoom account....

Secured new orders worth over S$4.7 million for precision cleaning systems in Singapore Developing autonomous cleaning robots for food and beverage establishments and industrial buildings Invested in carbon footprint reduction with electrification of vehicle fleet and installation of solar panelsSINGAPORE, May 01, 2024 (GLOBE NEWSWIRE) — Singapore-headquartered, NASDAQ-listed precision cleaning and cleantech equipment manufacturer JE Cleantech Holdings Ltd (NASDAQ: JCSE) (“JE Cleantech” or, together with its subsidiaries, the “Group”) has delivered a profitable performance in its annual report for the financial year ended December 31, 2023 (“2023 financial year”), with revenue of S$18.0 million and net income of S$0.5 million. The performance was recorded amid higher margin in its centralized dishware washing business segment,...